Molecular characteristics of differentiated-type gastric carcinoma with distinct mucin phenotype: LI-cadherin is associated with intestinal phenotype

Pathology International

Volumn 56, Issue 4, 2006, Pages 200-205

  Motoshita, Junichi ^a,b   Nakayama, Hirofumi ^a   Taniyama, Kiyomi ^b   Matsusaki, Keisuke ^c   Yasui, Wataru ^a  

^a HIROSHIMA UNIVERSITY   (Japan)

^b NATIONAL HOSPITAL ORGANIZATION   (Japan)

^c Hofu Institute of Gastroenterology   (Japan)

Author keywords

CD44v9; Differentiated type gastric carcinoma; E cadherin; Epidermal growth factor receptor; Immunohistochemistry; Liver intestine cadherin; Mucin phenotype; p53; Stomach

Indexed keywords

CADHERIN; CD44V ANTIGEN; CD44V9 ANTIGEN; EPIDERMAL GROWTH FACTOR RECEPTOR; MUCIN; PROTEIN P53; UNCLASSIFIED DRUG; UVOMORULIN;

ADVANCED CANCER; ARTICLE; CANCER STAGING; CORRELATION ANALYSIS; HUMAN; HUMAN CELL; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; INTESTINE; LIVER; MAJOR CLINICAL STUDY; MOLECULE; PHENOTYPE; PRIORITY JOURNAL; PROTEIN EXPRESSION; STOMACH CARCINOMA;

ADENOCARCINOMA; ANTIGENS, CD44; CADHERINS; HUMANS; IMMUNOHISTOCHEMISTRY; MUCINS; PHENOTYPE; RECEPTOR, EPIDERMAL GROWTH FACTOR; STOMACH NEOPLASMS; TUMOR MARKERS, BIOLOGICAL; TUMOR SUPPRESSOR PROTEIN P53;

EID: 33645300761     PISSN: 13205463     EISSN: 14401827     Source Type: Journal    
DOI: 10.1111/j.1440-1827.2006.01946.x     Document Type: Article

References (37)

1. Nakamura K Sugano H Takagi K. Carcinoma of the stomach in incipient phase: Its histogenesis and histological appearance. Gann 1968 59 251 8.
2. Lauren P. The two histological main types of gastric carcinoma: Diffuse and so-called intestinal type carcinoma: An attempt at histological classification. Acta Pathol Microbiol Scand 1965 64 31 49.
3. Fiocca R Villani L Tenti P et al. Characterization of four main cell types in gastric cancer: Foveolar, mucopeptic, intestinal columnar and goblet cells: An histopathologic, histochemical and ultrastructual study of 'early' and 'advanced' tumours. Pathol Res Pract 1987 182 308 25.
4. Tatematsu M Tsukamoto T Inada K. Stem cells and gastric cancer: Role of gastric and intestinal mixed intestinal metaplasia. Cancer Sci 2003 94 135 41.
5. Tatematsu M Tsukamoto T Mizoshita T. History of gastric carcinoma research in Japan: Basic aspects. In Kaminishi M Takubo K Mafune K eds. The Diversity of Gastric Carcinoma Pathogenesis: Diagnosis, and Therapy. Tokyo Springer 2005 3 28.
6. Koseki K Takizawa T Koike M Ito M Nihei Z Sugihara K. Distinction of differentiated type early gastric carcinoma with gastric type mucin expression. Cancer 2000 89 724 32.
7. Tajima Y Shimoda T Nakanishi Y et al. Gastric and intestinal phenotypic marker expression in gastric carcinomas and its prognostic significance: Immunohistochemical analysis of 136 lesions. Oncology 2001 61 212 20.
8. Endoh Y Sakata K Tamura G et al. Cellular phenotypes of differentiated-type adenocarcinomas and precancerous lesions of the stomach are dependent on the genetic pathways. J Pathol 2000 191 257 63.
9. Kushima R Muller W Stolte M Borchad F. Differential p53 protein expression in stomach adenomas of gastric and intestinal phenotypes: Possible sequences of p53 alteration in stomach carcinogenesis. Virchows Arch 1996 428 223 7.
10. Wu LB Kushima R Borchard F Molsberger G Hattori T. Intramucosal carcinomas of the stomach: Phenotypic expression and loss of heterozygosity at microsatellites linked to the APC gene. Pathol Res Pract 1998 194 405 11.
11. Shibata N Watari J Fujiya M Tanno S Saitoh Y Kohgo Y. Cell kinetics and genetic instabilities in differentiated type early gastric cancers with different mucin phenotype. Hum Pathol 2003 34 32 40.
12. Yokozaki H Shitara Y Fujimoto J Hiyama T Yasui W Tahara E. Alterations of p73 preferentially occur in gastric adenocarcinomas with foveolar epithelial phenotype. Int J Cancer 1999 83 192 6.
13. Motoshita J Oue N Nakayama H et al. DNA methylation profiles of differentiated-type gastric carcinomas with distinct mucin phenotypes. Cancer Sci 2005 96 474 9.
14. Yasui W Oue N Kitadai Y et al. Recent advances in molecular pathobiology of gastric carcinoma. In Kaminishi M Takubo K Mafune K eds. The Diversity of Gastric Carcinoma Pathogenesis: Diagnosis, and Therapy. Tokyo Springer 2005 51 71.
15. Yokozaki H Yasui W Tahara E. Genetic and epigenetic changes in stomach cancer. Int Rev Cytol 2001 204 49 95.
16. Yasui W Oue N Ono S Mitani Y Ito R Nakayama H. Histone acetylation and gastrointestinal carcinogenesis. Ann NY Acad Sci 2003 983 220 31.
17. Yasui W Oue N Aung PP Matsumura S Shutoh M Nakayama H. Molecular-pathobiological prognostic factors of gastric cancer: A review. Gastric Cancer 2005 8 86 94.
18. Shimada Y Yamasaki S Hashimoto Y et al. Clinical significance of dysadherin expression in gastric cancer patients. Clin Cancer Res 2004 10 2818 23 (Erratum Clin Cancer Res 2004 10 4198
19. Chen HC Chu RY Hsu PN et al. Loss of E-cadherin expression correlates with poor differentiation and invasion into adjacent organs in gastric adenocarcinomas. Cancer Lett 2003 201 97 106.
20. Mayer B Jauch KW Gunthert U et al. De-novo expression of CD44 and survival in gastric cancer. Lancet 1993 342 1019 22.
21. Ko S Chu KM Luk JM et al. Overexpression of LI-cadherin in gastric cancer is associated with lymph node metastasis. Biochem Biophys Res Commun 2004 319 562 8.
22. Ko S Chu KM Luk JM et al. CDX2 co-localized with liver-intestine cadherin in intestinal metaplasia and adenocarcinoma of the stomach. J Pathol 2005 205 615 22.
23. Ito R Oue N Yoshida K et al. Clinicopathological significant and prognostic influence of cadherin-17 expression in gastric cancer. Virchows Arch 2005 447 717 22.
24. Sobin LH, Wittekind CH eds. TNM Classification of Malignant Tumors 6th edn. New York Wiley-Liss 2002.
25. Yasui W Akama Y Kuniyasu H et al. Expression of cyclin-dependent kinase inhibitor p21WAF1/CIP1 in non-neoplastic mucosa and neoplasia of the stomach: Relation with p53 status and proliferative activity. J Pathol 1996 180 122 8.
26. Takamura M Sakamoto M Ino Y et al. Expression of liver-intestine cadherin and its possible interaction with galectin-3 in ductal adenocarcinoma of the pancreas. Cancer Sci 2003 94 425 30.
27. Shimoyama Y Hirohashi S. Expression of E- and P-cadherin in gastric carcinoma. Cancer Res 1991 51 2185 92.
28. Yasui W Hata J Yokozaki H et al. Interaction between epidermal growth factor and its receptor in progression of human gastric carcinoma. Int J Cancer 1988 41 211 17.
29. Ito R Nakayama H Yoshida K Matsumura S Oda N Yasui W. Expression of Cbl linking with the epidermal growth factor receptor system is associated with tumor progression and poor prognosis of human gastric carcinoma. Virchows Arch 2004 444 324 31.
30. 2+-dependent cell adhesion molecule expressed in liver and intestine. J Cell Biol 1994 125 1353 69.
31. Dantzig A Hoskins J Tabas L et al. Association of intestinal peptide transport with a protein related to the cadherin superfamily. Science 1994 264 430 33.
32. Oue N Hamai Y Mitani Y et al. Gene expression profile of gastric carcinoma: Identification of genes and tags potentially involved in invasion, metastasis, and carcinogenesis by serial analysis of gene expression. Cancer Res 2004 64 2397 405.
33. Yasui W Oue N Ito R Kuraoka K Nakayama H. Search for new biomarkers of gastric cancer through serial analysis of gene expression and its clinical implications. Cancer Sci 2004 95 385 92.
34. Almeida R Silva E Santos-Silva F et al. Expression of intestine-specific transcription factors, CDX1 and CDX2, in intestinal metaplasia and gastric carcinomas. J Pathol 2003 199 36 40.
35. Yamamoto H Bai YQ Yuasa Y. Homeodomain protein CDX2 regulates goblet-specific MUC2 gene expression. Biochem Biophys Res Commun 2003 300 813 18.
36. Eda A Osawa H Yanaka I et al. Expression of homeobox gene CDX2 precedes that of CDX1 during the progression of intestinal metaplasia. J Gastroenterol 2002 37 94 100.
37. Hinoi T Lucas PC Kuick R Hanash S Cho KR Fearon ER. CDX2 regulates liver intestine-cadherin expression in normal and malignant colon epithelium and intestinal metaplasia. Gastroenterology 2002 123 1565 7.